<DOC>
	<DOCNO>NCT00956267</DOCNO>
	<brief_summary>The purpose study compare determine efficacy letrozole administration laparoscopic ovarian diathermy ( LOD ) infertile woman Polycystic ovary syndrome ( PCOS ) respond treatment Clomiphene alone .</brief_summary>
	<brief_title>Letrozole Laparoscopic Ovarian Diathermy Women With CC Resistant Polycystic Ovary Syndrome .</brief_title>
	<detailed_description>In letrozole group , withdrawal bleeding achieve use 10 mg dydrogesterone tablet 10 day stimulation , 2.5 mg letrozole oral tablet ( Femara ; Novartis Pharma Services , Switzerland ) daily day 3 menses 5 day six cycle . All patient control group underwent laparoscopic ovarian diathermy , follow 6 month .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>CC resistant PCOS Congenital adrenal hyperplasia Cushing syndrome Androgen secreting tumor</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Polycystic ovary syndrome</keyword>
	<keyword>clomiphene resistance</keyword>
	<keyword>letrozole</keyword>
	<keyword>Laparoscopic ovarian diathermy</keyword>
</DOC>